Monday, July 28, 2014
My Account  | Login
Nashua;65.0;http://forecast.weather.gov/images/wtf/small/nskc.png;2014-07-28 22:33:57
img
Staff photo by Bob Hammerstrom

Atrium Medical Corp. headquarters in Hudson. The company plans to move to a location on Continental Boulevard in Merrimack.
Friday, April 27, 2012

Atrium Medical, with 450 employees, plans to move from Hudson to Merrimack

MERRIMACK – A medical device company bought last fall by a Swedish firm says it will move its headquarters, production facility and about 450 employees from Hudson to Merrimack, and plans to add some 250 employees down the road.

The move by Atrium Medical Corp. to an empty office park formerly occupied by Fidelity Investments was announced Thursday, but won’t happen quickly. It’s likely to take place sometime in the next 24 months, the company said.

The move will require Planning Board approval, as it would require some changes to the entrance, said Timothy J. Thompson, Community Development Director for the town.

Atrium has been on Wentworth Drive in a 140,000-square-foot building, part of an industrial park in south Hudson off Lowell Road, for 17 years. The company said the site “has reached its expansion limits and can no longer support the company’s growth demands.”

In its announcement, Atrium said it has plans to eventually expand its future home, a 115,000-square-foot, two-story structure at 40 Continental Blvd. in Merrimack. It would add 90,000 square feet for a medical manufacturing and research-and-design facility and boost total employment to 700 people.

Atrium has been in southern New Hampshire since it was founded 31 years ago. It was bought in October for $680 million by Swedish company Getinge Group and its subsidiary, Maquet Cardiovascular.

“Our company has grown tremendously over the last few years and is projected to continue expanding in the years to come,” said Trevor Carlton, Atrium president. “Moving our headquarters also allows us the opportunity to continue collaborating with leading clinicians and researchers from around the world to meet the demands for expansive, evidence-based clinical trials.”

Last year, Atrium said it wanted to build a new 300,000-square-foot manufacturing and office facility on Robert Milligan Parkway in Merrimack, but it withdrew the application from the town Planning Board in January.

At the time, Tim Thompson, Merrimack’s director of community development, said the company’s new owners weren’t interested in building new facilities and instead would rather focus on expanding an existing building.

Atrium develops and manufactures a variety of medical devices for the treatment of coronary and vascular disease, chest trauma, hernias, and soft-tissue injury. It has international offices in England, Germany, France, India, Australia and the Netherlands.

David Brooks can be reached at 594-6531 or dbrooks@nashuatelegraph.com.